Paysign, Inc. (NASDAQ:PAYS) Sees Significant Growth in Short Interest

Paysign, Inc. (NASDAQ:PAYS) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 462,000 shares, a growth of 24.1% from the December 31st total of 372,400 shares. Based on an average trading volume of 227,400 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.4% of the company’s shares are sold short.

Insider Activity

In related news, major shareholder Topline Capital Partners, Lp sold 20,834 shares of the firm’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $3.03, for a total value of $63,127.02. Following the transaction, the insider now directly owns 5,611,128 shares in the company, valued at approximately $17,001,717.84. This trade represents a 0.37 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Topline Capital Management, Ll sold 231,187 shares of the business’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $3.31, for a total transaction of $765,228.97. Following the transaction, the insider now directly owns 5,859,046 shares of the company’s stock, valued at approximately $19,393,442.26. This represents a 3.80 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 958,447 shares of company stock worth $3,046,524 over the last 90 days. 23.40% of the stock is owned by company insiders.

Institutional Trading of Paysign

Several large investors have recently made changes to their positions in the business. SG Americas Securities LLC bought a new position in Paysign in the 3rd quarter valued at $43,000. Algert Global LLC acquired a new position in shares of Paysign in the 2nd quarter valued at $46,000. The Manufacturers Life Insurance Company bought a new stake in shares of Paysign in the 2nd quarter valued at $66,000. American Century Companies Inc. bought a new position in Paysign during the second quarter worth about $92,000. Finally, Bard Associates Inc. bought a new stake in shares of Paysign in the third quarter worth about $103,000. Institutional investors own 25.89% of the company’s stock.

Paysign Stock Performance

Shares of PAYS stock traded down $0.12 during trading hours on Monday, hitting $2.54. The company had a trading volume of 312,004 shares, compared to its average volume of 283,510. The firm has a market capitalization of $136.01 million, a price-to-earnings ratio of 16.93 and a beta of 0.95. Paysign has a 12 month low of $2.46 and a 12 month high of $5.59. The firm’s fifty day moving average is $3.07 and its 200 day moving average is $3.83.

Paysign (NASDAQ:PAYS) last posted its earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The business had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. During the same quarter in the prior year, the firm earned $0.02 EPS. On average, sell-side analysts expect that Paysign will post 0.21 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on PAYS. Lake Street Capital assumed coverage on shares of Paysign in a research note on Friday, December 20th. They issued a “buy” rating and a $6.00 price objective on the stock. Barrington Research reaffirmed an “outperform” rating and set a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.